Revisiting Prostate Cancer Recurrence with PSMA PET: Atlas of Typical and Atypical Patterns of Spread

Imagem de Miniatura
Arquivos
art_BARBOSA_Revisiting_Prostate_Cancer_Recurrence_with_PSMA_PET_Atlas_2019.PDF (8.79 MB)
Citações na Scopus
58
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
RADIOLOGICAL SOC NORTH AMERICA
Autores
BARBOSA, Felipe G.
NUNES, Rafael F.
Citação
RADIOGRAPHICS, v.39, n.1, p.186-212, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The introduction of prostate-specific membrane antigen (PSMA) in clinical practice has revolutionized evaluation of biochemical recurrence of prostate cancer after curative-intent treatment. The high expression of this glycoprotein in prostate cancer cells makes PSMA imaging superior to the current conventional staging methods, namely bone scanning and CT. The high capability of PSMA imaging for identifying very small previously undetected lesions has been widely demonstrated in the literature, leading to a rethinking of patient management by oncologists, urologists, and radiation oncologists. The typical and predictable patterns of spread in prostate cancer are still more prevalent, such as spread to pelvic lymph nodes and bone metastasis, but different patterns of disease spread are becoming more commonly recognized with higher reliability because PSMA imaging allows detection of more typical and atypical lesions than conventional imaging. Furthermore, it is important for the reading physician to recognize and understand the typical disease spread and the most prevalent atypical prostate cancer relapses, not only to heighten the relevancy of reports but also to improve imaging consultancy in multispecialty oncologic practice. (C) RSNA, 2019.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/30832
Referências
  1. Afshar-Oromieh A, 2015, EUR J NUCL MED MOL I, V42, P197, DOI 10.1007/s00259-014-2949-6
  2. Afshar-Oromieh A, 2014, EUR J NUCL MED MOL I, V41, P11, DOI 10.1007/s00259-013-2525-5
  3. Allen SD, 2008, EUR RADIOL, V18, P1281, DOI 10.1007/s00330-008-0867-3
  4. Bach-Gansmo T, 2017, J UROLOGY, V197, P676, DOI 10.1016/j.juro.2016.09.117
  5. Backhaus P, 2018, EUR J NUCL MED MOL I, V45, P860, DOI 10.1007/s00259-017-3922-y
  6. Bader P, 2002, J UROLOGY, V168, P514, DOI 10.1016/S0022-5347(05)64670-8
  7. Ballas LK, 2016, J NUCL MED, V57, p6S, DOI 10.2967/jnumed.115.170142
  8. Baumann R, 2018, STRAHLENTHER ONKOL, V194, P318, DOI 10.1007/s00066-017-1239-1
  9. Bowrey DJ, 2003, ANN ROY COLL SURG, V85, P382, DOI 10.1308/003588403322520726
  10. Briganti A, 2012, PROSTATE, V72, P186, DOI 10.1002/pros.21420
  11. Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698
  12. Buyyounouski MK, 2017, CA-CANCER J CLIN, V67, P246, DOI 10.3322/caac.21391
  13. Calais J, 2018, J NUCL MED, V59, P789, DOI 10.2967/jnumed.117.203257
  14. Calais J, 2018, J NUCL MED, V59, P230, DOI [10.2967/jnumed.117.201749, 10.2967/jnumed.117.202945]
  15. Cellini N, 2002, INT J RADIAT ONCOL, V53, P595, DOI 10.1016/S0360-3016(02)02795-5
  16. Chakraborty PS, 2015, CLIN NUCL MED, V40, P328, DOI 10.1097/RLU.0000000000000709
  17. Chan M, 2017, CLIN NUCL MED, V42, P193, DOI 10.1097/RLU.0000000000001526
  18. Chang SS, 1999, CLIN CANCER RES, V5, P2674
  19. Choo MS, 2017, ANN SURG ONCOL, V24, P2047, DOI 10.1245/s10434-017-5822-6
  20. Cirillo S, 2009, EUR RADIOL, V19, P761, DOI 10.1007/s00330-008-1174-8
  21. de Crevoisier R, 2007, INT J RADIAT ONCOL, V68, P1529, DOI 10.1016/j.ijrobp.2007.01.069
  22. Dureja S, 2017, INDIAN J NUCL MED, V32, P13, DOI 10.4103/0972-3919.198450
  23. Eiber M, 2015, J NUCL MED, V56, P668, DOI 10.2967/jnumed.115.154153
  24. Einspieler I, 2017, J NUCL MED, V58, P1081, DOI 10.2967/jnumed.116.184457
  25. Ellis CL, 2015, AM J SURG PATHOL, V39, P67, DOI 10.1097/PAS.0000000000000289
  26. Fendler WP, 2017, EUR J NUCL MED MOL I, V44, P1014, DOI 10.1007/s00259-017-3670-z
  27. Fleshner K, 2017, NAT REV UROL, V14, P26, DOI 10.1038/nrurol.2016.251
  28. Freedland SJ, 2014, J CLIN ONCOL, V32, P3892, DOI 10.1200/JCO.2014.58.8525
  29. Freitag MT, 2017, EUR J NUCL MED MOL I, V44, P776, DOI 10.1007/s00259-016-3594-z
  30. Gakis G, 2014, EUR UROL, V66, P191, DOI 10.1016/j.eururo.2013.05.033
  31. Gandaglia G, 2014, PROSTATE, V74, P210, DOI 10.1002/pros.22742
  32. Gorin MA, 2017, PET CLIN, V12, P185, DOI 10.1016/j.cpet.2016.11.001
  33. Griffin N, 2011, INSIGHTS IMAGING, V2, P205, DOI 10.1007/s13244-011-0089-0
  34. Heck MM, 2014, EUR UROL, V66, P222, DOI 10.1016/j.eururo.2013.02.007
  35. Heck MM, 2014, EUR J NUCL MED MOL I, V41, P694, DOI 10.1007/s00259-013-2634-1
  36. Herlemann A, 2016, EUR UROL, V70, P553, DOI 10.1016/j.eururo.2015.12.051
  37. Hijazi S, 2016, PROSTATE, V76, P776, DOI 10.1002/pros.23168
  38. Hofman MS, 2018, RADIOGRAPHICS, V38, P200, DOI 10.1148/rg.2018170108
  39. Hokamp NG, 2017, CLIN NUCL MED, V42, P406, DOI 10.1097/RLU.0000000000001582
  40. Hope TA, 2017, J NUCL MED, V58, P1956, DOI 10.2967/jnumed.117.192476
  41. Hovels AM, 2008, CLIN RADIOL, V63, P387, DOI 10.1016/j.crad.2007.05.022
  42. Hruby G, 2017, RADIOTHER ONCOL, V122, P99, DOI 10.1016/j.radonc.2016.11.023
  43. International Agency for Research on Cancer, 2012, CANC FACT SHEETS PRO
  44. Jadvar H, 2018, J NUCL MED, V59, P228, DOI 10.2967/jnumed.117.203604
  45. Janssen JC, 2018, EUR RADIOL, V28, P610, DOI 10.1007/s00330-017-4994-6
  46. Janssen JC, 2017, MOL IMAGING BIOL, V19, P933, DOI 10.1007/s11307-017-1101-y
  47. Jilg CA, 2017, THERANOSTICS, V7, P1770, DOI 10.7150/thno.18421
  48. Keller ET, 2004, J CELL BIOCHEM, V91, P718, DOI 10.1002/jcb.10662
  49. Koppie TM, 2002, J UROLOGY, V168, P2120, DOI 10.1097/01.ju.0000032081.42658.ed
  50. Lange MB, 2016, EUR J RADIOL, V85, P61, DOI 10.1016/j.ejrad.2015.10.012
  51. Lazarus JA, 1935, AM J SURG, V30, P502
  52. Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351
  53. Long MA, 1999, BRIT J RADIOL, V72, P933, DOI 10.1259/bjr.72.862.10673942
  54. Malik D, 2018, CLIN NUCL MED, V43, P529, DOI 10.1097/RLU.0000000000002103
  55. Maurer T, 2016, J UROLOGY, V195, P1436, DOI 10.1016/j.juro.2015.12.025
  56. Mohler JL, 2016, J NATL COMPR CANC NE, V14, P19, DOI 10.6004/jnccn.2016.0004
  57. Mueller-Lisse UG, 2001, RADIOLOGY, V221, P380, DOI 10.1148/radiol.2211001582
  58. Murray SK, 2004, AM J SURG PATHOL, V28, P1154, DOI 10.1097/01.pas.0000131543.80147.3d
  59. National Comprehensive Cancer Network, 2017, PROST CANC VERS 2 20
  60. O'Keefe DS, 2018, J NUCL MED, V59, P1007, DOI 10.2967/jnumed.117.203877
  61. Osman MM, 2017, J NUCL MED, V58, P1938, DOI 10.2967/jnumed.117.190215
  62. Osmonov DK, 2014, ADV UROL, DOI 10.1155/2014/321619
  63. Ost P, 2016, CLIN ONCOL-UK, V28, pE115, DOI 10.1016/j.clon.2016.04.040
  64. Ost P, 2018, J CLIN ONCOL, V36, P446, DOI 10.1200/JCO.2017.75.4853
  65. Ost P, 2015, EUR UROL, V67, P852, DOI 10.1016/j.eururo.2014.09.004
  66. Panebianco V, 2015, INSIGHTS IMAGING, V6, P611, DOI 10.1007/s13244-015-0426-9
  67. Pano B, 2011, RADIOGRAPHICS, V31, P135, DOI 10.1148/rg.311105072
  68. Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755
  69. Perera M, 2016, EUR UROL, V70, P926, DOI 10.1016/j.eururo.2016.06.021
  70. Ploussard G, 2014, EUR UROL, V65, P7, DOI 10.1016/j.eururo.2013.03.057
  71. Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591
  72. Pucar D, 2008, CURR OPIN UROL, V18, P87, DOI 10.1097/MOU.0b013e3282f13ac3
  73. Pyka T, 2016, EUR J NUCL MED MOL I, V43, P2114, DOI 10.1007/s00259-016-3435-0
  74. Raleigh DR, 2015, BRACHYTHERAPY, V14, P185, DOI 10.1016/j.brachy.2014.11.008
  75. Rauscher I, 2016, J NUCL MED, V57, P1713, DOI 10.2967/jnumed.116.173492
  76. Rauscher I, 2016, CANCER IMAGING, V16, DOI 10.1186/s40644-016-0072-6
  77. SAITOH H, 1990, CANCER-AM CANCER SOC, V65, P1843, DOI 10.1002/1097-0142(19900415)65:8<1843::AID-CNCR2820650830>3.0.CO;2-4
  78. SAITOH H, 1984, CANCER-AM CANCER SOC, V54, P3078, DOI 10.1002/1097-0142(19841215)54:12<3078::AID-CNCR2820541245>3.0.CO;2-U
  79. Sanda MG, 2018, J UROLOGY, V199, P683, DOI 10.1016/j.juro.2017.11.095
  80. Sandgren K, 2017, EUR UROL FOCUS
  81. Schirrmeister H, 2001, J NUCL MED, V42, P1800
  82. Sella T, 2006, AM J ROENTGENOL, V186, P539, DOI 10.2214/AJR.04.1770
  83. Sella T, 2004, RADIOLOGY, V231, P379, DOI 10.1148/radiol.2312030011
  84. Serfling S, 2016, CLIN NUCL MED, V41, P792, DOI 10.1097/RLU.0000000000001302
  85. Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238
  86. Shipley WU, 2017, NEW ENGL J MED, V376, P417, DOI 10.1056/NEJMoa1607529
  87. Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442
  88. Thomas L, 2017, PHARMACEUTICALS, V10, DOI 10.3390/ph10030068
  89. Tosoian JJ, 2017, NAT REV UROL, V14, P15, DOI 10.1038/nrurol.2016.175
  90. Tulsyan S, 2017, NUCL MED COMMUN, V38, P1094, DOI 10.1097/MNM.0000000000000749
  91. Uprimny C, 2018, EUR J NUCL MED MOL I
  92. Uprimny C, 2017, EUR J NUCL MED MOL I, V44, P1647, DOI 10.1007/s00259-017-3743-z
  93. Uprimny C, 2017, EUR J NUCL MED MOL I, V44, P765, DOI 10.1007/s00259-016-3578-z
  94. Vaghefi H, 2005, UROLOGY, V66, P8817, DOI 10.1016/j.urology.2005.04.005
  95. van Leeuwen PJ, 2017, BJU INT, V119, P209, DOI 10.1111/bju.13540
  96. Vargas HA, 2012, RADIOLOGY, V262, P26, DOI 10.1148/radiol.11101996
  97. Vinjamoori AH, 2012, AM J ROENTGENOL, V199, P367, DOI 10.2214/AJR.11.7533
  98. Wallitt KL, 2017, RADIOGRAPHICS, V37, P1512, DOI 10.1148/rg.2017170035
  99. Walz J, 2011, CURR OPIN UROL, V21, P173, DOI 10.1097/MOU.0b013e3283449d6d
  100. Weiberg D, 2017, CLIN NUCL MED, V42, P563, DOI 10.1097/RLU.0000000000001659
  101. Werner RA, 2018, UROLOGY, V117, P18, DOI 10.1016/j.urology.2018.03.030
  102. Wibmer AG, 2016, RADIOGRAPHICS, V36, P142, DOI 10.1148/rg.2016150059
  103. Wilt TJ, 2017, NEW ENGL J MED, V377, P132, DOI 10.1056/NEJMoa1615869

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/43
Artigos e Materiais de Revistas Científicas - LIM/44
Carregar mais